A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin

Yuji Ukita; Hiroshi Tsubamoto; Toru Kato; Shigeo Suno; Hiroaki Shibahara

doi:10.1016/j.gynor.2013.07.004

A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin

Gynecol Oncol Case Rep. 2013 Jul 22:6:19-21. doi: 10.1016/j.gynor.2013.07.004. eCollection 2013.

Authors

Yuji Ukita¹, Hiroshi Tsubamoto¹, Toru Kato¹, Shigeo Suno², Hiroaki Shibahara¹

Affiliations

¹ Department of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
² Department of Obstetrics and Gynecology, Kinki Central Hospital, 3-1 Kurumazuka, Itami, Hyogo 664-8533, Japan.

Abstract

•Glassy cell carcinoma (GCC) of the cervix is rare and aggressive.•A few case reports have described a response to intravenous chemotherapy for this malignancy.•This is the first report of a GCC case that responded to a combination of docetaxel and carboplatin.

Keywords: Carboplatin; Cervical cancer; Chemotherapy; Docetaxel; Glassy cell carcinoma.